These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 7752216

  • 1. Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis.
    Ramadan MA, Tawfik AF, Shibl AM, Gemmell CG.
    J Med Microbiol; 1995 May; 42(5):362-6. PubMed ID: 7752216
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ, Sloos JH, Mouton RP, Van Boven CP, Van de Klundert JA.
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [Abstract] [Full Text] [Related]

  • 3. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V, Romero J, Herrera N, Marinkovic K, Bustos R.
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [Abstract] [Full Text] [Related]

  • 4. Cultural and electronmicroscopic studies of the effect of penicillin on tolerant oral streptococci.
    Holbrook WP, Kristinsson KG, Carley AJ, Gunnarsdóttir S.
    J Med Microbiol; 1989 Dec; 30(4):267-72. PubMed ID: 2600959
    [Abstract] [Full Text] [Related]

  • 5. In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes.
    Pruul H, Wetherall B, McDonald P.
    Eur J Clin Microbiol; 1986 Aug; 5(4):405-10. PubMed ID: 3530749
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effect of erythromycin on polymorphonuclear cell antibacterial activity against erythromycin-resistant phenotypes of Streptococcus pyogenes.
    Banche G, Tullio V, Allizond V, Mandras N, Roana J, Scalas D, El Fassi F, D'Antico S, Cuffini AM, Carlone N.
    Int J Antimicrob Agents; 2010 Oct; 36(4):319-23. PubMed ID: 20692129
    [Abstract] [Full Text] [Related]

  • 7. The erythromycin-resistance in S. pyogenes does not limit the human polymorphonuclear cell antimicrobial activity.
    Cuffini AM, Tullio V, Banche G, Allizond V, Mandras N, Roana J, Scalas D, Carlone NA.
    Int J Immunopathol Pharmacol; 2009 Oct; 22(1):239-42. PubMed ID: 19309572
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D, Rossetti R, Braga PC.
    Drugs Exp Clin Res; 2004 Sep; 30(1):17-26. PubMed ID: 15134387
    [Abstract] [Full Text] [Related]

  • 10. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
    Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, Seppälä H, Finnish Study Group for Antimicrobial Resistance (FiRe Network).
    Clin Infect Dis; 2004 May 01; 38(9):1251-6. PubMed ID: 15127336
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis.
    Longman LP, Pearce PK, McGowan P, Hardy P, Martin MV.
    J Med Microbiol; 1991 Jan 01; 34(1):33-7. PubMed ID: 1990136
    [Abstract] [Full Text] [Related]

  • 12. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z, Baysallar M, Gür D, Doğanci L.
    Mikrobiyol Bul; 2003 Oct 01; 37(4):225-34. PubMed ID: 14748258
    [Abstract] [Full Text] [Related]

  • 13. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
    Paulsen P, Simon C, Peters O, Hedderich J, Heim P.
    Chemotherapy; 1992 Oct 01; 38(3):185-90. PubMed ID: 1324831
    [Abstract] [Full Text] [Related]

  • 14. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
    Pascual A, López-López G, Aragón J, Perea EJ.
    Chemotherapy; 1990 Oct 01; 36(6):422-7. PubMed ID: 1963394
    [Abstract] [Full Text] [Related]

  • 15. In-vitro postantibiotic effects of miocamycin and erythromycin on gram-positive cocci.
    Varotto F, Garlaschi ML, Garlaschi MC, Falchi M, Scaglione F, Cattaneo G, De Luca M, Fraschini F.
    J Chemother; 1990 Dec 01; 2(6):355-61. PubMed ID: 2093106
    [Abstract] [Full Text] [Related]

  • 16. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV, Brasili S, Saiz M, Carranza C, Vidal P, Calderón J, Lopardo HA.
    Medicina (B Aires); 2000 Dec 01; 60(4):487-90. PubMed ID: 11188957
    [Abstract] [Full Text] [Related]

  • 17. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
    Chang JC, Hsueh PR, Young C.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov 01; 25(4):276-84. PubMed ID: 1342645
    [Abstract] [Full Text] [Related]

  • 18. Penicillin tolerance among oral streptococci.
    Holbrook WP, Olafsdóttir D, Magnússon HB, Benediktsdóttir E.
    J Med Microbiol; 1988 Sep 01; 27(1):17-22. PubMed ID: 3050106
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R, Sauermann R, Lagler H, Stich K, Buxbaum A, Graninger W, Georgopoulos A.
    Int J Antimicrob Agents; 2004 Sep 01; 24(3):290-3. PubMed ID: 15325435
    [Abstract] [Full Text] [Related]

  • 20. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
    Kaplan EL, Chhatwal GS, Rohde M.
    Clin Infect Dis; 2006 Dec 01; 43(11):1398-406. PubMed ID: 17083011
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.